The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
China Business & Economy

AstraZeneca Says Its Employees Under Investigation by Chinese Authorities

The new probe into pharmaceutical giant AstraZeneca comes as foreign investors’ confidence in the world’s second-largest economy wanes.
AstraZeneca Says Its Employees Under Investigation by Chinese Authorities
People walk in the access area of the AstraZeneca office in Shanghai, China, on Sept. 5, 2024. Hector Retamal/AFP via Getty Images
Dorothy Li
9/5/2024|Updated: 9/5/2024
0:00

Pharmaceutical giant AstraZeneca confirmed on Thursday that “a small number” of its employees are under investigation by the Chinese authorities.

In an email statement to The Epoch Times, an AstraZeneca spokesperson said the company is aware that “a small number of our employees in China are under investigation” and that it has “no further information to share at this point.”

Dorothy Li
Dorothy Li
Author
Dorothy Li is a reporter for The Epoch Times. Contact Dorothy at [email protected].
Author’s Selected Articles

Beijing Puts Trade Restrictions on US Companies as Friction Persists

Sep 25, 2025
Beijing Puts Trade Restrictions on US Companies as Friction Persists

Bipartisan Lawmakers Seek to Release Americans Wrongfully Detained in China

Sep 23, 2025
Bipartisan Lawmakers Seek to Release Americans Wrongfully Detained in China

UN, EU Demand That China Release Prominent COVID Whistleblower

Sep 22, 2025
UN, EU Demand That China Release Prominent COVID Whistleblower

US Lawmakers Push for Military Communication, Trade Talks in Rare Trip to China

Sep 21, 2025
US Lawmakers Push for Military Communication, Trade Talks in Rare Trip to China
Add to My List
Save
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.